By Editor , 30 September 2026
Lead Image
BodySpec Opens Oakland Location for Under-$60 Muscle and Bone Scans

Oakland – September 30, 2026 -- BodySpec has opened a new storefront in downtown Oakland offering medical-grade DEXA body scans for under $60, giving East Bay residents a fast way to track muscle mass, visceral fat, and bone density as GLP-1 weight-loss drug use rises.

The 12-minute scan measures body fat, visceral fat, lean muscle mass, and bone density, paired with a digital dashboard and a conversational AI agent that explains results and suggests personalized next steps.

By Editor , 17 September 2026
Lead Image
Meant Health Expands Telehealth Access to Ozempic and GLP-1 Prescriptions

Manassas – September 16, 2026 -- Meant Health has expanded its telehealth platform to connect patients with licensed U.S. clinicians for evaluation and prescription of FDA-approved GLP-1 medications, including Ozempic.

Patients start with an intake questionnaire before any prescription decision

The process begins with a questionnaire covering health history, current medications and treatment goals. A licensed clinician then reviews the submission and decides, case by case, whether a prescription is appropriate.

By Editor , 11 September 2026
Lead Image
Free AI Eye Scan Aims to Close Diabetes Screening Gap in Germany

Berlin – September 11, 2026 -- Diabetes can silently damage the eyes years before patients notice any change in their vision, yet new data show barely half of people with type 2 diabetes get the recommended eye exam. To close that gap, German health insurer mkk - meine krankenkasse now offers its members a free eye screening from Skleo Health at participating opticians and drugstores.

By Editor , 1 September 2026
Lead Image
Diabetic Cyclist Wins Climbing Title at Philadelphia Classic's Return

PHILADELPHIA -- September 01, 2026 -- David Lozano, a Spanish rider with type 1 diabetes, won the King of the Mountains classification at the Philadelphia Cycling Classic on Saturday, claiming the climber's jersey as America's most prestigious one-day race returned after a decade away. Lozano, who races for Team Novo Nordisk, the world's first all-diabetes professional cycling team, led the day's decisive breakaway over the Manayunk Wall and Lemon Hill. Teammate Filippo Ridolfo finished 12th, the team's top overall result on the day.